Policy development, politics, & government issues are a major part of healthcare. PolitiTalkRx is a podcast all about the politics that shape pharmacy policies within our healthcare system. Contact us to participate in this publication part of the leading podcast network dedicated to the ”Business of Pharmacy” -- the Pharmacy Podcast Network.
PolitiTalkRx
Claim This Podcastby Pharmacy Podcast Network
20 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Policy development, politics, & government issues are a major part of healthcare. PolitiTalkRx is a podcast all about the politics that shape pharmacy policies within our healthcare system. Contact us to participate in this publication part of the leading podcast network dedicated to the ”Business of Pharmacy” -- the Pharmacy Podcast Network.
Language
🇺🇲
Publishing Since
2/15/2018
1 verified contact email on file for PolitiTalkRx
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
August 12, 2021
ASHP on CMS Pass Through Funding | PolitalkRx
Tom Kraus VP, Government Relations at ASHP CMS pass through funding What is pass through funding for residency programs and why is it so important? On March 29th the US District Court of South Carolina granted MUSC Health’s motion for summary judgment again HHS for their disallowance of PGY1 residency costs. Can you provide some details/background on this case? What was the guidance that CMS was failing to provide? Can speak about ASHP’s work with CMS to make the guidance more apparent to other programs moving forward? What will be the downstream effect of this case on residency programs in the future? Can you break down the practice for our listeners? What are the concerns with white bagging? What are the steps being taken at the state and federal level to take action to the concerns related to white bagging? Co-signing letter to the FDA Leveraging PELA and SPPL; can you explain? Partnership with AHA Provider status Can you talk about the work ASHP has done to ensure that pharmacists can provide Medication-assisted treatment (MAT)? At the end of April the US House and Senate introduced the Pharmacy and Medically Underserved Areas Enhancement Act. A similar bill has been submitted for the past couple of years. Can you walk us through the history of this bill? What it would allow pharmacists to do? Why it is so important for the Country? Statistics? This bill continues to have bipartisan support. What do we need to do as pharmacists to finally get this passed? COVID-19 and its effect on provider status and Advocacy Since the start of COVID-19 we’ve seen congress put forth bills and amendments that outline the healthcare response to the pandemic. One such amendment to the PREP Act outlined that “any physician, advanced practice registered nurse, registered nurse, or practical nurse” who had a license within the last 5 years could participate in the vaccination effort, even if the license was inactive. Pharmacists were left out of this amendment originally. I believe that has since been updated, but what is it that we need to be doing as individuals within the profession to help government officials to understand the worth of pharmacists and consider them as a primary focus in any further legislation? Learn more about your ad choices. Visit megaphone.fm/adchoices
December 21, 2020
The Supreme Court Rules in Favor of Pharmacy | Locked On Pharmacy
On Dec. 10, 2020, the U.S. Supreme Court ruled 8-0 that an Arkansas law regulating how PBMs and pharmacies interact could be enforced, and was not preempted by federal law. With more than three dozen other states debating or passing such legislation, the ruling could have nationwide impact. The CEOs of national pharmacy organization were unanimous in hailing the decision. In this episode, three guests discuss the case: Rep. Buddy Carter (R-Georgia); John Vinson, CEO of the Arkansas Pharmacists Association; and Scott Knoer, Executive Vice President and CEO of the American Pharmacists Association. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
August 10, 2020
Georgia State Representative David Knight & GPhA Greg Reybold | PBM Reform Podcast Series
Georgia Gov. Brian Kemp (R) has signed three innovative PBM reform bills into law. HB 946 and SB 313 require the reporting of drugs paid 10 percent above and 10 percent below National Average Drug Acquisition Cost every four months, prohibit PBMs from tying a pharmacy’s drug reimbursement to a patient’s health outcomes, and require PBMs to offer drug coverage plans that do not include spread pricing and plans that allow plan sponsors to receive 100 percent of rebates negotiated by PBMs. HB 918 strengthens existing anti-steering provisions and the Pharmacy Audit Bill of Rights. Congratulations to the Georgia Pharmacy Association and all pharmacy advocates for these wins which will protect pharmacies, patients, and payers. Guests: Georgia State Representative David Knight Greg Reybold Vice President of Public Policy and Association Counsel Hosted by Lauren (Colee) Young Sponsored by The Georgia Pharmacy Association & Pharmacists United for Truth and Transparency (PUTT) http://www.gpha.org/membership/ See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
20 total episodes available
Deep-dive analytics for PolitiTalkRx
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is PolitiTalkRx?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.